These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 1796819)
1. Effect of topical corticosteroids on human sebum production assessed by two different methods. Lévêque JL; Pierard-Franchimont C; de Rigal J; Saint-Léger D; Piérard GE Arch Dermatol Res; 1991; 283(6):372-6. PubMed ID: 1796819 [TBL] [Abstract][Full Text] [Related]
2. Follicule to follicule heterogeneity of sebum excretion. Piérard GE Dermatologica; 1986; 173(2):61-5. PubMed ID: 3792601 [TBL] [Abstract][Full Text] [Related]
3. Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid. Lavker RM; Kaidbey K; Leyden JJ J Am Acad Dermatol; 1992 Apr; 26(4):535-44. PubMed ID: 1597538 [TBL] [Abstract][Full Text] [Related]
4. A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation. Oussedik E; Saleem MD; Feldman SR J Drugs Dermatol; 2017 Oct; 16(10):972-975. PubMed ID: 29036250 [TBL] [Abstract][Full Text] [Related]
6. Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans. Schmied C; Saurat JH Dermatologica; 1991; 182(2):107-11. PubMed ID: 2050230 [TBL] [Abstract][Full Text] [Related]
7. Long-term effects of topical corticosteroids in the nose. Bende M; Mark J J Laryngol Otol; 1992 Sep; 106(9):810-2. PubMed ID: 1431520 [TBL] [Abstract][Full Text] [Related]
8. The effects of potent topical corticosteroids on adrenocortical function. Aso M J Dermatol; 1983 Apr; 10(2):145-9. PubMed ID: 6352764 [No Abstract] [Full Text] [Related]
16. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay. Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion-imaging. Sommer A; Veraart J; Neumann M; Kessels A Acta Derm Venereol; 1998 Jan; 78(1):15-8. PubMed ID: 9498019 [TBL] [Abstract][Full Text] [Related]
18. Kinetics of sebum excretion evaluated by the Sebutape--Chromameter technique. Piérard GE; Piérard-Franchimont C; Kligman AM Skin Pharmacol; 1993; 6(1):38-44. PubMed ID: 8489774 [TBL] [Abstract][Full Text] [Related]
19. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis. Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961 [TBL] [Abstract][Full Text] [Related]
20. Sensitization studies with mometasone furoate, tixocortol pivalate, and budesonide in the guinea pig. Bruze M; Bjorkner B; Dooms-Goossens A Contact Dermatitis; 1996 Mar; 34(3):161-4. PubMed ID: 8833457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]